Annual Shareholders Equity
$73.39 M
-$37.98 M-34.10%
December 31, 2024
Summary
- As of March 13, 2025, HOWL annual stockholders equity is $73.39 million, with the most recent change of -$37.98 million (-34.10%) on December 31, 2024.
- During the last 3 years, HOWL annual shareholders equity has fallen by -$79.40 million (-51.97%).
- HOWL annual shareholders equity is now -51.97% below its all-time high of $152.79 million, reached on December 31, 2021.
Performance
HOWL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$73.39 M
-$15.99 M-17.89%
December 31, 2024
Summary
- As of March 13, 2025, HOWL quarterly stockholders equity is $73.39 million, with the most recent change of -$15.99 million (-17.89%) on December 31, 2024.
- Over the past year, HOWL quarterly shareholders equity has dropped by -$15.99 million (-17.89%).
- HOWL quarterly shareholders equity is now -59.58% below its all-time high of $181.56 million, reached on June 30, 2021.
Performance
HOWL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
HOWL Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -34.1% | -17.9% |
| 3 y3 years | -52.0% | -40.0% |
| 5 y5 years | +402.0% | -40.0% |
HOWL Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.0% | at low | -52.0% | at low |
| 5 y | 5-year | -52.0% | +241.5% | -59.6% | +147.7% |
| alltime | all time | -52.0% | +241.5% | -59.6% | +147.7% |
Werewolf Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $73.39 M(-34.1%) | $73.39 M(-17.9%) |
| Sep 2024 | - | $89.38 M(-14.1%) |
| Jun 2024 | - | $104.02 M(-11.5%) |
| Mar 2024 | - | $117.59 M(+5.6%) |
| Dec 2023 | $111.37 M(-9.0%) | $111.37 M(-1.0%) |
| Sep 2023 | - | $112.44 M(-5.2%) |
| Jun 2023 | - | $118.60 M(-2.0%) |
| Mar 2023 | - | $121.07 M(-1.0%) |
| Dec 2022 | $122.34 M | $122.34 M(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $130.95 M(+0.9%) |
| Jun 2022 | - | $129.84 M(-6.8%) |
| Mar 2022 | - | $139.32 M(-8.8%) |
| Dec 2021 | $152.79 M(-394.6%) | $152.79 M(-9.8%) |
| Sep 2021 | - | $169.30 M(-6.7%) |
| Jun 2021 | - | $181.56 M(-218.1%) |
| Mar 2021 | - | -$153.75 M(+196.5%) |
| Dec 2020 | -$51.86 M(+113.4%) | -$51.86 M |
| Dec 2019 | -$24.30 M | - |
FAQ
- What is Werewolf Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Werewolf Therapeutics?
- What is Werewolf Therapeutics annual shareholders equity year-on-year change?
- What is Werewolf Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly shareholders equity year-on-year change?
What is Werewolf Therapeutics annual stockholders equity?
The current annual shareholders equity of HOWL is $73.39 M
What is the all time high annual shareholders equity for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual stockholders equity is $152.79 M
What is Werewolf Therapeutics annual shareholders equity year-on-year change?
Over the past year, HOWL annual stockholders equity has changed by -$37.98 M (-34.10%)
What is Werewolf Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of HOWL is $73.39 M
What is the all time high quarterly shareholders equity for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly stockholders equity is $181.56 M
What is Werewolf Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, HOWL quarterly stockholders equity has changed by -$15.99 M (-17.89%)